Literature DB >> 23176980

Evaluation of 238 antigens of Leptospira borgpetersenii serovar Hardjo for protection against kidney colonisation.

Gerald L Murray1, Miranda Lo, Dieter M Bulach, Amporn Srikram, Torsten Seemann, Noelene S Quinsey, Rasana W Sermswan, Andy Allen, Ben Adler.   

Abstract

Leptospirosis is a zoonotic disease affecting animals and humans worldwide. Leptospiral infection in cattle can cause reproductive failure and reduced weight gain, and importantly, infection represents a significant disease risk for farmers. Current bacterin vaccines offer protection that is short-lived and restricted at best to related serovars. The development of protective vaccines that stimulate immunity across multiple leptospiral serovars would therefore be advantageous. This study used a reverse vaccinology approach to evaluate a set of Leptospira borgpetersenii proteins in the hamster infection model. The L. borgpetersenii serovar Hardjo strain L550 genome sequence was analysed and genes encoding 262 predicted outer membrane or secreted proteins were selected. From this list, 238 proteins or protein fragments were successfully expressed and purified; 28 proteins (12%) were soluble, while the remaining 210 proteins (88%) were insoluble and purified under denaturing conditions. Proteins were mixed into 48 pools of up to five each and tested for protection against infection as assessed by renal colonisation in the hamster model of infection. None of the pools of antigens protected the hamsters against infection, despite a detectable antibody response being mounted against the majority of proteins (71%). This study is the first large scale evaluation of individual leptospiral proteins for ability to induce a protective immune response in the hamster infection model. It thus constitutes an important reference of protein immunogenicity and non-protective antigens that should be consulted before embarking on any future subunit vaccine experiments.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23176980     DOI: 10.1016/j.vaccine.2012.11.028

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

Review 1.  Human leptospirosis vaccines in China.

Authors:  Yinghua Xu; Qiang Ye
Journal:  Hum Vaccin Immunother       Date:  2017-12-19       Impact factor: 3.452

2.  Protective Immunity and Reduced Renal Colonization Induced by Vaccines Containing Recombinant Leptospira interrogans Outer Membrane Proteins and Flagellin Adjuvant.

Authors:  D Monaris; M E Sbrogio-Almeida; C C Dib; T A Canhamero; G O Souza; S A Vasconcellos; L C S Ferreira; P A E Abreu
Journal:  Clin Vaccine Immunol       Date:  2015-06-24

3.  Leptospiral outer membrane protein LipL41 is not essential for acute leptospirosis but requires a small chaperone protein, lep, for stable expression.

Authors:  Amy M King; Thanatchaporn Bartpho; Rasana W Sermswan; Dieter M Bulach; Azad Eshghi; Mathieu Picardeau; Ben Adler; Gerald L Murray
Journal:  Infect Immun       Date:  2013-05-20       Impact factor: 3.441

Review 4.  Reverse Vaccinology: An Approach for Identifying Leptospiral Vaccine Candidates.

Authors:  Odir A Dellagostin; André A Grassmann; Caroline Rizzi; Rodrigo A Schuch; Sérgio Jorge; Thais L Oliveira; Alan J A McBride; Daiane D Hartwig
Journal:  Int J Mol Sci       Date:  2017-01-14       Impact factor: 5.923

5.  Immunoprotective properties of recombinant LigA and LigB in a hamster model of acute leptospirosis.

Authors:  Karen V Evangelista; Kristel Lourdault; James Matsunaga; David A Haake
Journal:  PLoS One       Date:  2017-07-13       Impact factor: 3.240

6.  Discovery of Novel Leptospirosis Vaccine Candidates Using Reverse and Structural Vaccinology.

Authors:  André Alex Grassmann; Frederico Schmitt Kremer; Júlia Cougo Dos Santos; Jéssica Dias Souza; Luciano da Silva Pinto; Alan John Alexander McBride
Journal:  Front Immunol       Date:  2017-04-27       Impact factor: 7.561

7.  A Universal Vaccine against Leptospirosis: Are We Going in the Right Direction?

Authors:  André Alex Grassmann; Jéssica Dias Souza; Alan John Alexander McBride
Journal:  Front Immunol       Date:  2017-03-09       Impact factor: 7.561

8.  LigB subunit vaccine confers sterile immunity against challenge in the hamster model of leptospirosis.

Authors:  Neida L Conrad; Flávia W Cruz McBride; Jéssica D Souza; Marcelle M Silveira; Samuel Félix; Karla S Mendonça; Cleiton S Santos; Daniel A Athanazio; Marco A Medeiros; Mitermayer G Reis; Odir A Dellagostin; Alan J A McBride
Journal:  PLoS Negl Trop Dis       Date:  2017-03-16

9.  A live attenuated-vaccine model confers cross-protective immunity against different species of the Leptospira genus.

Authors:  Elsio A Wunder; Haritha Adhikarla; Camila Hamond; Katharine A Owers Bonner; Li Liang; Camila B Rodrigues; Vimla Bisht; Jarlath E Nally; David P Alt; Mitermayer G Reis; Peter J Diggle; Philip L Felgner; Albert Ko
Journal:  Elife       Date:  2021-01-26       Impact factor: 8.140

10.  Evaluation of the Leptospira interrogans Outer Membrane Protein OmpL37 as a Vaccine Candidate.

Authors:  Thaís Larré Oliveira; André Alex Grassmann; Rodrigo Andrade Schuch; Amilton Clair Pinto Seixas Neto; Marcelo Mendonça; Daiane Drawanz Hartwig; Alan John Alexander McBride; Odir Antônio Dellagostin
Journal:  PLoS One       Date:  2015-11-20       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.